0001104659-22-000978.txt : 20220104
0001104659-22-000978.hdr.sgml : 20220104
20220104170928
ACCESSION NUMBER: 0001104659-22-000978
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Westby Keith
CENTRAL INDEX KEY: 0001696429
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 22507284
MAIL ADDRESS:
STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
tm221330-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-31
0
0001410939
IVERIC bio, Inc.
ISEE
0001696429
Westby Keith
C/O IVERIC BIO, INC.
5 PENN PLAZA, SUITE 2372
NEW YORK
NY
10001
0
1
0
0
SVP & COO
Common Stock
2021-12-31
4
M
0
32500
A
140558
D
Common Stock
2022-01-03
4
S
0
12278
16.3923
D
128280
D
Restricted Stock Units
2021-12-31
4
M
0
32500
0
D
Common Stock
32500
0
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 31, 2021.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.77 to $16.77 on January 3, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
On December 9, 2019, the Reporting Person was granted 65,000 restricted stock units, which vest with respect to 50% of the shares subject to the award on December 31, 2020 and with respect to the remaining 50% of the shares subject to the award on December 31, 2021, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.
/s/ Todd Anderman, as Attorney-in-Fact for Keith Westby
2022-01-04